Skip to main content

Results for Compound Libraries ( 194 )

    • Ref: L1310
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: €5,789.00

      A unique collection of 773 cytoskeleton-related compounds, can be used for HTS and HCS;

      Product detail
    • Ref: L1380
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: €5,199.00

      Well-chosen 704 compounds with unique structures targeting transcription factor;

      Product detail
    • Ref: L1400
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: €2,793.00

      A unique collection of 367 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;

      Product detail
    • Ref: L1500
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: €9,569.00

      A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

      Product detail
    • Ref: L1510
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: €3,859.00

      A unique collection of 546 nuclear receptor signaling targeted compounds for high throughput and high content screening;

      Product detail
    • Ref: L1580
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: €2,475.00

      Well-chosen 338 GPCR targeting compounds with unique structures;

      Product detail
    • Ref: L1600
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: €13,019.00

      A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases;

      Product detail
    • Ref: L1700
      Sizes: 1 mg, 100 μL, 30 μL, 250 μL, 50 μL
      From: €3,292.00

      A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

      Product detail
    • Ref: L1710
      Sizes: 100 μL, 30 μL, 250 μL, 50 μL
      From: €4,767.00

      A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents;

      Product detail